companydata.dkcompanydata.dk

PHARMA PRODUCTION ApS: Financial statements 2018

CVR: 66108813

Source: annual report 2018, Danish Business Authority

01/10/2017 – 30/09/2018

PHARMA PRODUCTION ApS (CVR 66108813) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 871,554 and a net result of DKK 208,281 compared with DKK 667,377 the year before. That is a decrease of 19.6% compared with the year before. Equity in the 2018 report amounted to DKK 15,293,354. The solvency ratio was 58.3%. The company had 1 employee in the financial year.

Gross Profit
DKK 871,554
Profit/Loss
DKK 208,281
Equity
DKK 15,293,354
Total Assets
DKK 26,233,821
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-872 t.208 t.15.3 mio.1
2017-1.1 mio.667 t.15.1 mio.1
2016-1.2 mio.599 t.14.4 mio.-
2015-1.1 mio.487 t.13.8 mio.-
2014-964 t.237 t.13.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

PHARMA PRODUCTION ApS: The 2017 annual report is outMar 1, 2018

PHARMA PRODUCTION ApS has published its annual report for 2017. Gross profit came to DKK 1,084,269, and the net result was DKK 667,377.

About PHARMA PRODUCTION ApS

PHARMA PRODUCTION ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 1980. The company is registered under the industry Bogføring og revision; skatterådgivning. The company was previously named MEDICAPHARMA ApS and MATERIALISTEN GRAVENSGADE 8, AALBORG ApS. The management consists of Finn Jørgen Jensen. The company is owned by Bispensgade Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 19,077 and a net result of DKK -95,659 compared with DKK -20,470 the year before. Equity in the 2025 report amounted to DKK 16,469,125.

Source: annual report 2025, Danish Business Authority